急性脑梗死的治疗进展

[1] 基于血浆纤维蛋白原水平的降纤酶方案治疗急性脑梗死的临床研究[J]. 蔡晓斌,朱治山,张明之,郭瑾,王辉兰.南方医科大学学报. 2009(10)

[2] Is Thrombolysis Safe in the Elderly?: Analysis of a National Database[J] . Amer Alshekhlee,Afshin Mohammadi,Sonal Mehta,Randall C. Edgell,Nirav Vora,Eli Feen,Sushant Kale,Zaid A. Shakir,Salvador Cruz-Flores.Stroke . 2010 (10)

[3] Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke: Real-World Experience and a Call for Action[J] . Rohit Bhatia,Michael D. Hill,Nandavar Shobha,Bijoy Menon,Simerpreet Bal,Puneet Kochar,Tim Watson,Mayank Goyal,Andrew M. Demchuk.Stroke . 2010 (10)

[4] Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L): Final Results[J] . Thomas M. Hemmen,Rema Raman,Kama Z. Guluma,Brett C. Meyer,Joao A. Gomes,Salvador Cruz-Flores,Christine A. Wijman,Karen S. Rapp,James C. Grotta,Patrick D. Lyden.Stroke . 2010 (10)

[5] Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice: The Japan post-Marketing Alteplase Registration Study (J-MARS)[J] . Jyoji Nakagawara,Kazuo Minematsu,Yasushi Okada,Norio Tanahashi,Shinji Nagahiro,Etsuro Mori,Yukito Shinohara,Takenori Yamaguchi.Stroke . 2010 (9)

[6] Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients [J]. STROKE, 2010, 41 (09) : 1996 - 2000

[7] Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR[J] . Niaz Ahmed,Nils Wahlgren,Martin Grond,Michael Hennerici,Kennedy R Lees,Robert Mikulik,Mark Parsons,Risto O Roine,Danilo Toni,Peter Ringleb.Lancet Neurology . 2010 (9)

[8] Analysis of the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Studies Following European Cooperative Acute Stroke Study III Patient Selection Criteria [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2010, 19 (04) : 290 - 293

[9] Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J] . Kennedy R Lees,Erich Bluhmki,Rüdiger von Kummer,Thomas G Brott,Danilo Toni,James C Grotta,Gregory W Albers,Markku Kaste,John R Marler,Scott A Hamilton,Barbara C Tilley,Stephen M Davis,Geoffrey A Donnan,Werner Hacke.The Lancet . 2010 (9727)

[10] Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry) [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (04) : 445 - 452

[1] 基于血浆纤维蛋白原水平的降纤酶方案治疗急性脑梗死的临床研究[J]. 蔡晓斌,朱治山,张明之,郭瑾,王辉兰.南方医科大学学报. 2009(10)

[2] Is Thrombolysis Safe in the Elderly?: Analysis of a National Database[J] . Amer Alshekhlee,Afshin Mohammadi,Sonal Mehta,Randall C. Edgell,Nirav Vora,Eli Feen,Sushant Kale,Zaid A. Shakir,Salvador Cruz-Flores.Stroke . 2010 (10)

[3] Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke: Real-World Experience and a Call for Action[J] . Rohit Bhatia,Michael D. Hill,Nandavar Shobha,Bijoy Menon,Simerpreet Bal,Puneet Kochar,Tim Watson,Mayank Goyal,Andrew M. Demchuk.Stroke . 2010 (10)

[4] Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L): Final Results[J] . Thomas M. Hemmen,Rema Raman,Kama Z. Guluma,Brett C. Meyer,Joao A. Gomes,Salvador Cruz-Flores,Christine A. Wijman,Karen S. Rapp,James C. Grotta,Patrick D. Lyden.Stroke . 2010 (10)

[5] Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice: The Japan post-Marketing Alteplase Registration Study (J-MARS)[J] . Jyoji Nakagawara,Kazuo Minematsu,Yasushi Okada,Norio Tanahashi,Shinji Nagahiro,Etsuro Mori,Yukito Shinohara,Takenori Yamaguchi.Stroke . 2010 (9)

[6] Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients [J]. STROKE, 2010, 41 (09) : 1996 - 2000

[7] Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR[J] . Niaz Ahmed,Nils Wahlgren,Martin Grond,Michael Hennerici,Kennedy R Lees,Robert Mikulik,Mark Parsons,Risto O Roine,Danilo Toni,Peter Ringleb.Lancet Neurology . 2010 (9)

[8] Analysis of the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Studies Following European Cooperative Acute Stroke Study III Patient Selection Criteria [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2010, 19 (04) : 290 - 293

[9] Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J] . Kennedy R Lees,Erich Bluhmki,Rüdiger von Kummer,Thomas G Brott,Danilo Toni,James C Grotta,Gregory W Albers,Markku Kaste,John R Marler,Scott A Hamilton,Barbara C Tilley,Stephen M Davis,Geoffrey A Donnan,Werner Hacke.The Lancet . 2010 (9727)

[10] Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry) [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (04) : 445 - 452